Literature DB >> 9433341

Spontaneous dyskinesia in subjects with schizophrenia spectrum personality.

S L Cassady1, H Adami, M Moran, R Kunkel, G K Thaker.   

Abstract

OBJECTIVE: The study of spontaneous dyskinesia in schizophrenia is confounded by the widespread use of neuroleptics. The authors hypothesized that spontaneous dyskinesia would be present in subjects with schizophrenia spectrum personality (schizoid, paranoid, or schizotypal). They also tested the hypothesis that dyskinetic-like movements would increase after repeated dextroamphetamine challenge to the dopaminergic system.
METHOD: Dyskinetic-like movements were assessed in 34 spectrum subjects and 22 normal subjects; nine subjects from each group were administered both placebo and repeated dextroamphetamine challenges.
RESULTS: Spectrum subjects had more dyskinetic-like movements than normal subjects. Spontaneous dyskinesia was present in 12% of the spectrum subjects but was not seen in the normal subjects. Subjects with schizotypal personality had more dyskinetic-like movements than subjects with schizoid personality or normal subjects. Dyskinesia was present in 24% of the schizotypal subjects but not in the other groups. Dyskinetic movement scores correlated with positive symptom scores. With repeated amphetamine challenge, normal subjects showed a pattern of behavioral sensitization (an increase in dyskinetic-like movements), but spectrum subjects showed an abnormal response (fewer dyskinetic-like movements).
CONCLUSIONS: Dyskinesia and dyskinetic-like movements are more common in subjects with schizophrenia spectrum personality (primarily schizotypal) than in normal subjects and are related to positive symptoms. A failure of normal behavioral sensitization mechanisms after dextroamphetamine challenge is seen in subjects with schizophrenia spectrum personality.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9433341     DOI: 10.1176/ajp.155.1.70

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

Review 1.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

2.  Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period.

Authors:  Vijay A Mittal; Elaine F Walker; Carrie E Bearden; Deborah Walder; Hanan Trottman; Melita Daley; Anthony Simone; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2010-03-15       Impact factor: 13.382

3.  Deeper into schizotypy and motor performance: Investigating the nature of motor control in a non-psychiatric sample.

Authors:  Matthew W Roché; Mark L Fowler; Mark F Lenzenweger
Journal:  Psychiatry Res       Date:  2015-03-23       Impact factor: 3.222

Review 4.  Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk.

Authors:  A L Wolff; G A O'Driscoll
Journal:  J Psychiatry Neurosci       Date:  1999-09       Impact factor: 6.186

Review 5.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

6.  Structural brain changes in First Episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysis.

Authors:  Bayanne Olabi; Ian Ellison-Wright; Ed Bullmore; Stephen M Lawrie
Journal:  BMC Psychiatry       Date:  2012-08-07       Impact factor: 3.630

7.  Movement disorders in neuroleptic-naïve patients with schizophrenia spectrum disorders.

Authors:  Moges Ayehu; Teshome Shibre; Barkot Milkias; Abebaw Fekadu
Journal:  BMC Psychiatry       Date:  2014-10-09       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.